Evaluation of isotryptamine derivatives at 5-HT2 serotonin receptors

被引:32
作者
Chang-Fonga, J
Addo, J
Dukat, M
Smith, C
Mitchell, NA
Herrick-Davis, K
Teitler, M
Glennon, RA
机构
[1] Virginia Commonwealth Univ, Sch Pharm, Dept Med Chem, Richmond, VA 23298 USA
[2] Albany Med Coll, Ctr Neuropharmacol & Neurosci, Albany, NY 12208 USA
关键词
D O I
10.1016/S0960-894X(01)00713-2
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
On the basis that meta-chlorophenylpiperazine (mCPP: 1) is a nonselective 5-HT2C agonist. that benz-fused tryptamines (e.g., 5) display enhanced 5-HT2 affinity, and that certain isotryptamines 3 reportedly bind with enhanced affinity and selectivity at 5-HT2C receptors, we prepared and examined a series of isotryptamine-related analogues as potentially selective 5-HT2C agonists. None of the compounds displayed selectivity for 5-HT2C versus 5-HT2A receptors. Detailed re-examination of a compound previously reported to display 100-fold 5-HT2C selectivity [i.e.. S(+)-5,6-aifluoro-alpha-methylisotryptamine] revealed that its selectivity versus 5-HT2A receptors was, at best. only 10-fold. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:155 / 158
页数:4
相关论文
共 13 条
[1]   Novel agonists of 5HT(2C) receptors. Synthesis and biological evaluation of substituted 2-(indol-1-yl)-1-methylethylamines and 2-(indeno[1,2-b]pyrrol-1-yl)-1-methylethylamines. Improved therapeutics for obsessive compulsive disorder [J].
Bos, M ;
Jenck, F ;
Martin, JR ;
Moreau, JL ;
Sleight, AJ ;
Wichmann, J ;
Widmer, U .
JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (17) :2762-2769
[2]   Synthesis, pharmacology and therapeutic potential of 10-methoxypyrazino[1,2-a]indoles, partial agonists at the 5HT(2C) receptor [J].
Bos, M ;
Jenck, F ;
Martin, JR ;
Moreau, JL ;
Mutel, V ;
Sleight, AJ ;
Widmer, U .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 1997, 32 (03) :253-261
[3]   SYNTHESIS AND EVALUATION OF A NOVEL SERIES OF N,N-DIMETHYLISOTRYPTAMINES [J].
GLENNON, RA ;
JACYNO, JM ;
YOUNG, R ;
MCKENNEY, JD ;
NELSON, D .
JOURNAL OF MEDICINAL CHEMISTRY, 1984, 27 (01) :41-45
[4]  
GLENNON RA, 1991, MED CHEM RES, V1, P201
[5]  
GLENNON RA, 1999, PSYCHOPHARMACOLOGY G
[6]   The 5-HT2C receptor as a potential therapeutic target for the design of antiobesity and antiepileptic drugs [J].
Isaac, M .
DRUGS OF THE FUTURE, 2001, 26 (04) :383-393
[7]   Pyrrolo[3,2,1-ij]quinoline derivatives, a 5-HT2c receptor agonist with selectivity over the 5-HT2a receptor:: Potential therapeutic applications for epilepsy and obesity [J].
Isaac, M ;
Slassi, A ;
O'Brien, A ;
Edwards, L ;
MacLean, N ;
Bueschkens, D ;
Lee, DKH ;
McCallum, K ;
De Lannoy, I ;
Demchyshyn, L ;
Kamboj, R .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2000, 10 (09) :919-921
[8]  
KENNETT GA, 1993, CURR OPIN INVEST DR, V2, P317
[9]  
MOKROSZ JL, 1993, MED CHEM RES, V3, P240
[10]  
Olivier B., 1997, SEROTONIN RECEPTORS